INTRODUCTION
T cells continuously patrol the body, sensing pathogen entry by T cell receptor (TCR) recognition of proteolytic pathogen fragments displayed on the cell surface bound to major histocompatibility complex (MHC) proteins (York and Rock, 1996) . Only a very small fraction of naive T cells in the repertoire recognizes a given peptide (in mice, $20-200 cells) (Moon et al., 2007) . Thus, peptides acquired in intracellular compartments need to be displayed by MHC proteins on the cell surface for extended time periods for efficient recruitment of naive T cells into an antimicrobial response. MHC class II (MHCII) molecules present peptides from exogenous (and some internal) antigens to CD4 T cells that coordinate ensuing immune responses (Cresswell, 1994) . The importance of CD4 T cells is illustrated by the severity of AIDS in patients infected with HIV (Gandhi and Walker, 2002) .
MHCII proteins aggregate in the absence of peptide (Germain and Rinker, 1993; Rabinowitz et al., 1998) , and the hydrophobic peptide-binding groove is initially protected by invariant chain (Roche and Cresswell, 1990b) . Upon arrival in a late endosomal compartment, invariant chain is degraded by several proteases, leaving class-II-associated invariant chain peptides (CLIP) in the peptide-binding groove (Riberdy et al., 1992; Roche and Cresswell, 1991) . DM (HLA-DM in humans, H2-DM in mice) catalyzes CLIP dissociation, stabilizes empty MHCII proteins, and enables rapid binding of microbial peptides generated by limited proteolysis (Denzin and Cresswell, 1995; Denzin et al., 1996; Kropshofer et al., 1997; Sherman et al., 1995; Sloan et al., 1995) . A substantial antigen-presentation defect is observed in human cell lines and mouse strains deficient in DM expression (Fung-Leung et al., 1996; Martin et al., 1996; Mellins et al., 1990; Miyazaki et al., 1996; Morris et al., 1994) .
DM can catalyze dissociation of any MHCII-bound peptide and drives selection of peptides with the highest binding affinity (Katz et al., 1996; Sloan et al., 1995; Weber et al., 1996) . This selection process (also referred to as ''editing'') has a major impact on the peptide repertoire: DM extinguishes presentation of many low-affinity peptides, while greatly enhancing presentation of high-affinity binders. For example, direct quantification of peptides from hen egg lysozyme bound to I-A k (a murine MHCII protein) showed that the abundance of the immunodominant peptide was reduced >1,100-fold in the absence of DM (Lovitch et al., 2003) . The structural mechanisms of DM-driven peptide selection are not well understood. Mutagenesis experiments identified large lateral surfaces of DM and MHCII proteins involved in the interaction, and several mutants have implicated a region in the vicinity of the peptide N terminus (Anders et al., 2011; Doebele et al., 2000; Painter et al., 2011; Pashine et al., 2003) . A central problem is that most peptides bind with similar on-rates to MHCII proteins, and many ''low-affinity'' peptides have a half-life of several hours (Rabinowitz et al., 1998) . It is unknown how DM antagonizes presentation of peptides with a t 1/2 of <14 hr, while enhancing display of peptides with a t 1/2 of >33 hr (Lazarski et al., 2006) . The structure of a MHCII-DM complex is required to answer these questions, but this has been a significant challenge for the field since the structures of the individual proteins were reported (Brown et al., 1993; Fremont et al., 1998; Mosyak et al., 1998; Stern et al., 1994) . This challenge is closely related to the function of DM, which is to stabilize an unknown MHCII conformational intermediate that binds peptides with rapid kinetics.
RESULTS

Crystallization of the HLA-DM-HLA-DR1 Complex
We recently showed that DM does not detectably bind to HLA-DR (a human MHCII protein, abbreviated as DR) when the groove is fully occupied by a covalently linked peptide. Rather, DM binding requires truncation of several N-terminal peptide residues, including the anchor for the P1 pocket (Anders et al., 2011) . The hydrophobic P1 pocket is critical for stable peptide binding to DR molecules: mutation of the P1 peptide side chain to a polar residue prevents stable binding, whereas introduction of an aromatic residue into a polyalanine sequence (with a single lysine at a TCR contact residue) yields a high-affinity DR1 binder (Jardetzky et al., 1990; Stern et al., 1994) . We reasoned that covalent linkage of an N-terminally truncated peptide might enable crystallization of the DM-DR1 complex by trapping of a short-lived DM-sensitive DR1 conformer ( Figure 1A ). Soluble DR1 was first expressed with a full-length low-affinity peptide (CLIP Low ) and the linker between the peptide C terminus and the N terminus of the DRb chain (Kozono et al., 1994) was cut with endoproteinase GluC. CLIP Low was then exchanged with an N-terminally truncated peptide, which was trapped in the groove under mildly oxidizing conditions by formation of a disulfide bond between a cysteine at peptide position P6 and DR aV65C. This peptide was similar to the influenza hemagglutinin ) peptide previously used to crystallize DR1 (Stern et al., 1994) , but lacked three N-terminal residues (P-2, P-1, and P1) and thus spanned from P2 to P11. Initial cocrystallization experiments did not yield crystals. However, it was previously shown that the DM and DR transmembrane domains increase DM activity $200-fold to 400-fold by properly positioning the molecules (Weber et al., 2001) . Similarly, attachment of leucine zippers to both b chains yielded an active complex . We mimicked this positioning effect by linking DRb and DMb C termini using sortase A, a transpeptidase from Staphylococcus aureus (Mao et al., 2004; Mazmanian et al., 1999) . This directional approach avoided formation of homodimers of input proteins, a problem encountered during attempts to link DM and DR through a disulfide bond. Sortase A cleaves the peptide bond between threonine and glycine of a C-terminal LPATG motif and forms a covalent bond with the N-terminal amino group of an oligo-glycine. We attached the sortase tag to DRb and linked a peptide with N-terminal glycine residues to an introduced cysteine at the C terminus of the DMb extracellular domain. The linked DM-DR1 complex crystallized under a variety of different conditions, and structures were determined for crystals grown at pH 5.5 and 6.5. DM has optimal activity at an acidic pH (Denzin and Cresswell, 1995) , and the description therefore focuses primarily on the pH 5.5 structure.
Overview of the HLA-DM-HLA-DR1 Complex The structure of the complex of DM and DR1 was determined at a resolution of 2.6 Å in space group P2 1 2 1 2 1 (one molecule in the asymmetric unit). The structure was refined to final R/R free factors of 19.7/24.1% (Table S1 ). An example of electron density at the interface is shown in Figure S1A . There are no crystal contacts involving the peptide or DR1 helices in relevant parts of the groove (Figures S1C and S1D; Table S2 ). No electron density for the linker is observed in either of the two structures. The distance between the C termini of DRb and DMb is 19.9 Å , and no electron density is visible for 25 amino acids and a maleimide group connecting the C termini (extended length of $75 Å ).
The ectodomains of DM and DR1 are oriented parallel to each other, consistent with their colocalization on membranes in late endosomal compartments ( Figures 1C and 1D ). The area of the DM-DR1 interface is 1,595 Å 2 and the shape complementarity is 0.644. The interface is dominated by the a chains of DM and DR1 (66% of interface) ( Figure 1C and Movies S1 and S2). DM binds to a lateral surface of the DRa1 domain, close to the peptide-binding groove, without contacting the DRb1 domain or obstructing the open end of the groove where peptide N termini can exit ( Figures 1B, 1E , and 1F). In fact, a large cavity is present at this site, explaining how long antigen fragments can bind before being trimmed to shorter peptides (Castellino et al., 1998; Nelson et al., 1997) . The interface with the DRa1 domain is formed by DMa1 and, to a lesser extent, DMb1 (Figures 1B, 1C, and 1E; . A small interface among the b2 domains of DM and DR (19.5% of total) stabilizes the overall topology ( Figure S2E ). Previously reported mutations localize to the DM-DR interface (Anders et al., 2011; Doebele et al., 2000; Painter et al., 2011; Pashine et al., 2003) , providing independent support for the structure (Figures 2A and 2B ). The linked peptide spans from P2 to P11, but unambiguous density is only observed for the P5-P11 segment ( Figures 1B and 1E) . Thus, more than half of the binding groove is largely devoid of peptide.
Flipping of DR aW43 from the P1 Pocket toward DM In the previously reported DR1/HA 306-318 structure (Protein Data Bank ID code [PDB] 1DLH) (Stern et al., 1994) , DR aW43 forms a lateral wall of the P1 pocket and interacts with the P1 tyrosine . These residues are located at the DM-DR1 interface, except DR aP96 (mutation introduces glycan), DM bA55 (residue not surface exposed), and DM bE8 (mutation to lysine may affect DM conformation). DR aF51 and aE55 have moved into the peptide-binding groove in the DM-DR1 complex, as described in Figures 4 and 5.
(legend continued on next page) of the HA peptide ( Figure 3A ). In addition, it stabilizes residues in the vicinity of the P1 pocket through many interactions. In the DM-DR1 complex, aW43 is rotated out of the groove and its indole ring nitrogen forms a hydrogen bond with DM aN125 (Figures 3B and 3D ; Figures S3A-S3D ). DM aN125 lies on the edge of a hydrophobic pocket with which the indole ring interacts ( Figure 3E ; Table S2 ). The interaction between DR aW43 and DM aN125 represents a key feature of the complex. Mutation of DM aN125 to alanine results in an almost complete loss of DM activity ( Figure 3F ; Figure S3E ), and responsiveness to DM is greatly reduced by a conservative DR aW43F mutation (Anders et al., 2011) . Also, both residues are entirely conserved among DMA and DRA homologs across all examined species, including chicken ( Figure 2C ). DR aW43 is even conserved in coelacanth, an ancient fish species that was thought to be extinct before its rediscovery. DR aW43 is also conserved among the polymorphic human DQA and DPA genes (except DPA1*01:10, possibly a loss-of-function variant).
(C) Conservation of key contact residues. Alignments focus on the DR1 a1 domain (residues 31-61) and two segments of DMa (residues 91-101 and 121-141). Interacting residues are colored blue (DRa) and yellow (DMa). Sequences were retrieved from http://www.ensembl.org (June 2012). Key DRa-DMa contact residues are highlighted in red; DR residues that have moved into the groove are colored green. See also Figure S2 . In MHC class I (MHCI) molecules, the entire peptide-binding groove is flanked by two long a helices (a1 and a2) (Bjorkman et al., 1987) . In MHCII-peptide complexes, the a chain does not form a helix along the entire length of the peptide. Rather, DRa chain residues 52-55 form a short strand parallel to the bound peptide ( Figure 3A ) which is stabilized by conserved hydrogen bonds to the backbone of N-terminal peptide residues (P-2, P-1, and P1) (Stern et al., 1994) . This entire region is substantially changed in the DM-DR1 complex. The strand and the neighboring 3 10 helix (DR a46-50) ( Figure 3A ) are merged into a helix ( Figures 3B and 3C) . Essentially, this results in formation of an extended helix from DR a46 to 77, with a break at A56-G58. This conformational change would not be possible without the DR aW43 flip, which creates the required void. The conformational change is facilitated by loss of stabilizing interactions of aW43 with neighboring structural elements, including the b sheet floor of the groove, the 3 10 helix (DR a46-50), and the DR a52-55 strand ( Figures 3A and 3B ).
In addition, substantial conformational changes are observed on the floor of the peptide-binding groove in the vicinity of the P1 pocket. In the DR1-HA 306-318 structure, strands S3 and S4 (residues a29-35 and a39-44, respectively) are in a strained conformation. In the DM-DR1 structure, both strands have moved away from the DRa1 helix and toward the main b sheet platform ( Figure 3B ), which positions two key residues of the S4 strand and S3/S4 loop (DR aE40 and aK38, respectively) at the interface with DM ( Figure 3D ; Figures S1A and S1B). These charged residues form an extended hydrogen-bonding network that includes DM aD183, aR98, and aH180 ( Figure 3D ; Figures  S3F and S3G ). The importance of this network is highlighted by previous mutagenesis data: mutation of DM aR98 greatly impairs DM function (Anders et al., 2011) , whereas mutation of DR aE40 results in unresponsiveness to DM (Doebele et al., 2000) .
Stabilization of the P1 Pocket by DR aF51 and bF89
Previous mutagenesis studies showed that mutation of DR aF51 to alanine abrogates responsiveness to DM (Doebele et al., 2000; Painter et al., 2011) . F51 points out of the groove in the DR1-HA 306-318 structure ( Figure 4A ), which suggested that it represents an important DM interaction site close to the peptide N terminus. However, the structure of the DM-DR1 complex reveals a dramatic repositioning of F51 into the P1 pocket (a 13Å movement, measured from the tip of the phenyl ring) (Figures 4B and 5B; Figure S4 ). This movement results from folding of the DR a52-55 strand into a helical conformation and the accompanied helix tilt, as described above ( Figures 3B and 3C ). In the DM-DR1 complex, F51 thus stabilizes the most hydrophobic site of the groove (Figures 4B and 5B) . The P1 area is further stabilized by a conformational change in the DR b86-91 segment that positions bF89 near the P1 pocket where it closely interacts with DR aF51 (Figures 5C and 5D ). This explains why empty DR molecules are stable when bound to DM (Kropshofer et al., 1997) .
The P1 pocket of DR1 is optimally filled by bulky aromatic residues, and we tested DR aF51 mutants for DM binding (Figure 5E ) and DM-catalyzed peptide exchange ( Figure 5F ). The size of the hydrophobic DR a51 residue was critically important for DM binding, with a tryptophan at this position having more activity than the wild-type phenylalanine, whereas smaller leucine and valine mutants were less responsive (some HLA-DR alleles have a smaller P1 pocket, which accommodates a phenylalanine residue but not tyrosine or tryptophan). A previously reported DRb G86Y mutation fills the P1 pocket and would prevent the conformational changes we describe for the DM-DR1 structure, consistent with the observation that this mutation greatly reduces responsiveness to DM (Chou and Sadegh-Nasseri, 2000) .
DR aE55 also moves into the groove where it forms a watermediated hydrogen bond with DR bN82 ( Figure 4B ; Figure S5 ). The bidentate hydrogen bonds formed by DR bN82 and the P2 peptide backbone ( Figure 4A ) make a crucial contribution to stable peptide binding: mutation of this residue accelerates peptide dissociation from DR1 $3,000-fold (Zhou et al., 2009 ). Movement of DR aE55 into the groove may therefore contribute to peptide dissociation.
Effect of pH on DM-DR1 Conformation DM activity is regulated by pH, with an optimum in the 5.0-5.5 range of late endosomes. We determined a second structure at pH 6.5 in order to examine how pH affects the DM-DR1 interaction (Figure 6 ; Tables S1 and S3). Surface plasmon resonance (SPR) studies demonstrated DM binding by DR1 with a linked P2-P11 peptide at pH 6.5, with an $3-fold lower affinity compared to pH 5.5 ( Figures S6A and S6B) . The complex crystallized in the same space group (P2 1 2 1 2 1 , one molecule in the asymmetric unit), and the unit cell dimensions are similar to the pH 5.5 condition. Overall, the pH 6.5 structure is very similar to the pH 5.5 structure with an overall root-meansquare deviation (rmsd) of 0.44. Also, the overall interface with DM is similar, including the interaction of DR aW43 and DM aN125.
However, several major differences are evident. Very little density is present for the P2-P4 peptide segment in the pH 5.5 structure (with some residual density in the P4 pocket) (Figure 6A ). This peptide segment is presumably in rapid motion and may bind at a low occupancy. Also, the P5 residue is pointing out of the groove and even the linked P6 residue is elevated. Mass spectrometry analysis confirmed the presence of the entire P2-P11 peptide in crystals grown at pH 5.5 (data not shown). In contrast, at pH 6.5, electron density is observed [306] [307] [308] [309] [310] [311] [312] [313] [314] [315] [316] [317] [318] peptide showing aF51 (yellow), aF54 (green), and aE55 and bN82 (both red). aF51 is pointing out of the groove and aE55 is located outside the binding site. DR bH81 (dotted line) is rendered transparent to improve visibility of DR bN82. DR b82 forms bidentate hydrogen bonds with the peptide backbone at P2. (B) In the DM-DR1 complex, aF51 has moved into the P1 pocket, stabilizing this hydrophobic site. DR aE55 has moved into the groove where it forms a water-mediated hydrogen bond with DR bN82. See also Figure S4 .
for all peptide residues at full occupancy ( Figure 6B ), and the conformation of the peptide backbone is similar to the DR1-HA 306-318 structure. These pH-dependent differences in peptide electron density were confirmed by generating simulated annealing omit maps (Fo-Fc) in which the peptide model was omitted (data not shown).
Interestingly, DR aF51 is not located in the P1 pocket in the pH 6.5 structure, but at an intermediate position compared to the pH 5.5 DM-DR1 and DR1-HA 306-318 structures ( Figures 6C  and 6D ). DR bF89 is located outside the groove and does not stabilize DR aF51 in the P1 pocket ( Figures 6C and 6D) . Also, DR aE55 is present in a different rotamer in the pH 6.5 structure that does not sterically hinder access of peptide P2 to DR bN82 but rather forms a hydrogen bond with P2 (Figure 6C) . The pH 6.5 structure thus shows an intermediate conformation of the DM-DR complex in which the P1 pocket is not fully stabilized and DR aE55 does not sterically hinder the P2 peptide residue.
A pair of acidic DM residues, bD31 and bE47, was previously shown to contribute to the pH dependence of DM activity (Nicholson et al., 2006) . Both residues interact with DR1 in the pH 5.5 structure, but DM bE47 is located outside the interface at pH 6.5 (Figures 6E and 6F; Figures S6E-S6J ; Table S3 ). These changes Figure 3F . See also Figure S5 . affect the position of several DR residues, including DR aQ57, aE55, and aF54 (Figures 6E and 6F ; Figures S6E-S6J ). The relevance of these interactions is supported by a DR aQ57A mutation, which reduces DM activity in a pH-dependent manner ( Figure S6D ).
Model of DM-Driven Peptide Selection
Proteolytic degradation of invariant chain leaves CLIP in the DR peptidebinding groove (Figure 7, step 1) . No DM binding is detectable when the DRbinding groove is fully occupied by a peptide. The peptide N terminus needs to dissociate from the groove, a step that may be closely linked with flipping of DR aW43 (highlighted in red) away from the P1 pocket (step 2). The flipped DR aW43 side chain becomes a key DM interaction residue, and three DR1 residues move into the groove (step 2 to step 3). In the DM-bound state, these DR1 residues (DR aF51, bF89, and aE55, circled) stabilize the empty groove. Incoming peptides bind with rapid kinetics, but part of the groove initially remains inaccessible, driving a rapid peptide exchange process (step 4). Only peptides that successfully compete with DR residues for access to the P2 site and the P1 pocket are stably bound. Full occupancy of the groove reverses the conformational changes associated with DM binding and results in DM dissociation (step 5). DM thus binds an otherwise labile transition state in which a peptide is partially bound in the groove. It stabilizes such conformers and thereby reduces the energetic barriers associated with peptide dissociation and binding (Weber et al., 1996) .
DISCUSSION
The two structures provide mechanistic insights into three central aspects of DM function: DM-catalyzed peptide dissociation, DM-dependent stabilization of empty DR, and rapid selection of high-affinity peptides by the DM-DR complex.
How Does DM Accelerate Dissociation of Peptides from DR?
A series of studies showed that DM greatly accelerates dissociation of CLIP and other peptides from DR molecules, but the structural mechanisms have remained largely unclear (Denzin and Cresswell, 1995; Sherman et al., 1995; Sloan et al., 1995) . We previously reported that DM binding can only be detected when the peptide N terminus has dissociated from the DR groove (Anders et al., 2011) , and the structure provides a mechanistic explanation for this finding. Loss of hydrogen bonds with the peptide backbone (at P-2, P-1, and P1) is required for folding of the DR a52-55 segment into a helical conformation, and the peptide P1 anchor residue needs to vacate the P1 pocket for movement of the DR aF51 side chain into this hydrophobic site.
The structures suggest that flipping of DR aW43 away from the P1 pocket and dissociation of the peptide N terminus are closely linked events. Rotation of the DR aW43 side chain out of the groove should destabilize the P1 pocket and favor dissociation of the peptide N terminus. Alternatively, if the N terminus dissociates first, then the resulting loss of hydrophobic packing interactions with the P1 side chain should facilitate rotation of the DR aW43 side chain away from the P1 pocket. In the absence of DM, the most likely outcome is a rapid reversal of these conformational changes, depending on the DR-binding affinity of the more C-terminal parts of a peptide. The structures further suggest that flipping of DR aW43 is important for subsequent conformational changes. In the structure of the DR1-HA [306] [307] [308] [309] [310] [311] [312] [313] [314] [315] [316] [317] [318] complex, DR aW43 forms lateral packing interaction with the b sheet floor of the groove (DR aF32), the 3 10 helix (DR aF48), and the DR a52-55 strand (Stern et al., 1994) . In the DM-bound state, substantial conformational changes are observed for all three structural elements. The most significant change is the formation of a longer tilted a-helical segment stretching from DR a46-55. DR aW43 would clash with this helical segment if its side chain would not move away from the P1 pocket, suggesting that the DR aW43 flip is an early step in this sequence. This conformational change repositions DR aF51 into the P1 pocket, a step that is critical for DM binding, as shown by extensive mutagenesis experiments.
DM and DR molecules are localized on the same endosomal membranes, prepositioning them for the lateral interaction mode seen in the structure (Pashine et al., 2003) . Indeed, the presence of DM and DR transmembrane domains enhances DM activity $200-to 400-fold Weber et al., 2001) . It is possible that low-affinity, short-lived binding interactions can occur between the membrane-proximal immunoglobulin domains of DM and DR when both molecules are membrane tethered. The DM a1 and b1 domains may thus be able to rapidly interact with a short-lived DR conformer in which the peptide N terminus is outside the groove and DR aW43 is available for binding to DM aN125. Both residues are fully conserved among all examined species, and their importance in the DM-DR interaction is further underscored by mutagenesis experiments.
Comparison of the pH 5.5 and 6.5 structures identifies another feature relevant for DM-catalyzed peptide dissociation. A large body of work has shown that spontaneous peptide dissociation from MHCII molecules is greatly accelerated by a low pH, even in the absence of DM (Reay et al., 1992) . Furthermore, DM activity (C) Differences in position of key DR residues at pH 6.5 (colored) and pH 5.5 (gray); pH 5.5 residues (*). (D) Space filling model of hydrophobic DR residues of P1 pocket in pH 6.5 structure, DR aF51 (yellow) located partially in P1 site, and bF89 (red) outside the groove. (E and F) Differences in the interaction of an acidic pair (DMb D31-E47) with DR1 at pH 5.5 (E) and pH 6.5 (F). See also Figure S6. is highly pH dependent, with an optimum at the pH of late endosomes (pH 4.5-5.5) (Sloan et al., 1995) . Very little electron density is observed for the P2-P4 peptide segment in the pH 5.5 structure, but the entire covalently linked peptide (from P2 to P11) is bound at pH 6.5. Of particular interest is the pair of acidic DMb D31-E47 residues that interact with each other at pH 5.5, but have moved apart at pH 6.5. Mutation of both residues to the corresponding carboxamide (DMb D31N-E47Q) was previously shown to extend the pH range of DM activity ($9-fold increase of DM activity at neutral pH) (Nicholson et al., 2006) . These data suggest that the DMb D31-E47 pair may be (partially) protonated at pH 5.5, but deprotonated at a higher pH. These changes affect the interaction with DRa, in particular the conformation of the critical DR a54-57 segment: only at the lower pH, the side chain of DR aE55 forms a water-mediated hydrogen bond with DR bN82. In this position, DR aE55 sterically hinders an interaction between the peptide P2 residue and DR bN82 and prevents formation of energetically important hydrogen bonds (Zhou et al., 2009) .
The following steps are thus important for peptide dissociation: Short-lived DM-sensitive DR conformers form following dissociation of the peptide N terminus from the DR groove. Rotation of DR aW43 out of the groove creates a key DM interaction site and makes other conformational changes energetically more favorable. Rebinding of the peptide N terminus is inhibited by movement of DR residues into the P1 pocket (DR aF51 and bF89). Peptide dissociation is further accelerated by loss of hydrogen bonds between the peptide backbone at P2 and DR bN82. This scenario is supported by the two structures and a large body of functional data. It should be noted that these steps are unlikely to always occur in a particular sequence. For example, a peptide may completely dissociate prior to DM binding if it has a very low affinity for the DR molecule. However, alternative conformations, including inactive states of the DR molecule, become more likely when a large part of the groove is devoid of peptide (Painter et al., 2008; Rupp et al., 2011) . Given that DM can accelerate peptide dissociation >1,000-fold (Weber et al., 1996) , it must bind to most DR molecules prior to complete peptide dissociation.
How Does HLA-DM Stabilize Empty MHC Class II Molecules? Empty DR1 rapidly transitions into an inactive state (the halflife is allele dependent, $5 min for DR1), yet DR molecules maintain a highly peptide-receptive conformation in the presence of DM (Grotenbreg et al., 2007; Kropshofer et al., 1997; Rabinowitz et al., 1998) . DM-DR complexes have been purified from cells and were found to be largely devoid of peptide (Denzin et al., 1996; Kropshofer et al., 1997; Sanderson et al., 1996) . Furthermore, SPR experiments showed that empty DR dissociates from DM with very slow kinetics (Anders et al., 2011) . Movement of DR aF51 and bF89 into the P1 site protects the most hydrophobic part of the groove and prevents transition into alternative, inactive conformers with a tendency to aggregate. Stable empty MHCII-DM complexes are functionally important: DM deficiency results in an antigen-presentation defect even for MHCII proteins that do not require DM for CLIP dissociation, due to a low affinity for CLIP (Koonce et al., 2003) . Rapid binding to MHCII molecules protects proteolytic fragments from degradation, and proteolytic trimming can occur after binding to a MHCII molecule (Castellino et al., 1998; Nelson et al., 1997) .
How Does DM Enable Rapid Selection of the HighestAffinity Peptide Ligands? The mechanisms of DM-catalyzed peptide selection have been difficult to explain. All peptides have similar on-rates and differ primarily in their off-rates (Rabinowitz et al., 1998) . The structure implies how peptide editing can occur with rapid kinetics, even though peptides have a very long half-life (many hours or days) when fully bound in the groove (Jardetzky et al., 1990; Roche and Cresswell, 1990a) . In the pH 5.5 DM-DR1 structure, the two most important structural elements for stable peptide binding are inaccessible: the P1 pocket and the DR bN82 side chain. Incoming peptides thus need to compete with DR1 residues for access to these binding sites, which creates an energetic and kinetic barrier for full occupancy of the groove. This mechanism ensures that high-affinity peptides, which are present in limited quantities in the loading compartment (Germain and Hendrix, 1991) , are not outcompeted by low-affinity peptides. This proposed mechanism is supported by functional experiments in which DM and DR1 were linked by leucine zippers. Peptides dissociated with very rapid kinetics from this linked complex: CLIP with a t 1/2 of 10 s and HA 306-318 with a t 1/ 2 of 2 min (note that HA 306-318 has a t 1/2 of $1 month in the absence of DM) .
Structural features along the entire peptide are relevant for DM editing (Belmares et al., 2002; Weber et al., 1996) , even though DM interacts with a site close to the peptide N terminus. Anchor residues in the middle and C-terminal part of the peptide need to properly engage available pockets (such as P4, P6, and P9) during the initial stages of binding, positioning peptides to access DR bN82 and the P1 pocket. Peptides without a hydrophobic P1 anchor do not induce DR dissociation from DM and are subject to continued editing (Anders et al., 2011) . This mechanism explains how DM catalyzes selection of peptides with a very long half-life for presentation on the cell surface.
Which Mechanisms Limit DM-Catalyzed Displacement of High-Affinity Peptides? SPR experiments have shown that peptides induce dissociation of a complex of DM and empty DR, depending on the affinity of the peptide for the DR molecule (Anders et al., 2011) . This result can now be explained based on the new structures: the peptide P1 anchor and DR aF51 compete for access to the same DR1 pocket. DM binding is abrogated by the DR aF51A mutation. This suggests that insertion of a hydrophobic peptide side chain into the P1 pocket is one of the key steps that trigger DM dissociation from the complex. High-affinity peptides thus rapidly terminate editing, and rebinding of such DR-peptide complexes to DM occurs with slow kinetics (Anders et al., 2011) .
Relevance for MHCI Molecules MHCI molecules bind peptides in the endoplasmic reticulum (ER) that are generated by the proteasome and transported into the ER by the TAP (transporter associated with processing) heterodimer. Empty MHCI molecules become part of the ''peptide-loading complex''; they are bound by calreticulin and the disulfide-linked tapasin-ERp57 dimer, which also recruits them to the TAP heterodimer (Chen and Bouvier, 2007; Peaper and Cresswell, 2008; Sadegh-Nasseri et al., 2008; Wearsch and Cresswell, 2007) . Even though all involved proteins, the compartment, and the pH are different, the essential problem for peptide loading is the same: how are empty molecules stabilized in a manner that enables rapid selection of the highestaffinity ligands? The tapasin-ERp57 heterodimer appears to stabilize the N-terminal part of the a2 helix of MHCI molecules (which flanks the C-terminal part of peptides) (Dong et al., 2009) . Also, monoclonal antibodies (such as mAb 64-3-7) have been identified that bind to peptide-receptive but not peptideloaded states of a MHCI molecule. The 64-3-7 antibody recognizes a short peptide segment of the MHCI heavy chain corresponding to a 3 10 helix (residues 46-52) in the vicinity of the peptide N terminus. In the peptide-loaded state, a conserved tryptophan residue (W51) and M52 buttress invariant tyrosine residues (Y59 and Y171) at the amino-terminal end of the peptide-binding groove. W51 and M52 become solvent-exposed in the peptide-receptive form, apparently by movement of the 3 10 helix containing W51 and M52 (Mage et al., 2012) . Conformational changes in the vicinity of the peptide N terminus may thus be relevant for not only peptide-receptive states of MHCII but also MHCI molecules.
EXPERIMENTAL PROCEDURES
Crystallization, Data Collection, and Structure Determination Crystallization trials were performed by hanging drop vapor diffusion at room temperature. Crystals appeared under a variety of different conditions. Crystals from two conditions were used for structure determination: (1) 0.2 M sodium acetate, 0.1 M sodium citrate (pH 5.5), 10% PEG 4,000; (2) 0.1 M MES (pH 6.5), 6% PEG 20,000. Crystals were cryoprotected using either 30% (v/v) ethylene glycol or 20% (v/v) glycerol and flash-frozen in liquid nitrogen. Diffraction data were collected at 100 K at the NE-CAT beamline 24-ID-E while performing a continuous vector scan over the crystal. The data were processed with the HKL2000 program, and the structure was determined by molecular replacement using HLA-DR1 (1DLH) and HLA-DM (1HDM) as search models (for details, see Extended Experimental Procedures). Atomic coordinates and structure factors for the reported crystal structures have been deposited under PDBs 4FQX (pH 5.5) and 4GBX (pH 6.5).
Biacore Analysis of DM-DR Binding
Mutations were introduced into HLA-DR15 (DRA*01:01, DRB1*15:01) because a large body of data is available for comparison (Anders et al., 2011) . The sequence of the DRa chain is identical for DR1 and DR15. DR15-CLIP binding to DM was measured by SPR using a Biacore 3000 instrument (GE Healthcare). Wild-type and mutant DM were biotinylated at a BirA site on the C terminus of DMa and captured on a streptavidin surface ($500 response units [RU] ). DR15-CLIP complexes were diluted in running buffer (50 mM citratephosphate [pH 5.35], 150 mM NaCl, 0.06% C12E9 detergent) immediately prior to injection. DR15-CLIP WT and indicated mutants were injected at 25 ml/min (stage 1, DR binding to DM), followed by running buffer (stage 2, dissociation of empty DR from DM) and a peptide (myelin basic protein, MBP residues 85-99, 1 mM) that binds to DR15 (stage 3, dissociation of DRpeptide from DM) (300 s for each stage) (Anders et al., 2011) . Experiments were performed at 30 C. Measurements from the reference flow cell (immobilized DM double mutant, DMa R98A-R194A) were subtracted from experimental values.
Peptide-Binding Assay A real-time assay was used to assess binding of a fluorescent peptide to DR15, employing a fluorescence polarization (FP, mP units) readout (Nicholson et al., 2006) . The linker connecting the CLIP peptide to the N terminus of the DRb chain was cut with thrombin (1 hr, 20 U/mg, at room temperature). DR15-CLIP complexes (150 nM) were incubated ±DM (typically 25 nM) in the presence of a high-affinity Alexa-488-labeled MBP 85-99 peptide (30 nM) at 30 C. Assays were set up in a volume of 40 ml in black polystyrene 384-well plates (Corning, NY, USA) in 50 mM citrate (pH 5.2) at 30 C (triplicates). Initial binding rates were calculated using Graphpad 5.0. The Extended Experimental Procedures describe details on the formation of the DM-DR1 complex not described in the Results and Figure 1 , as well as structure determination.
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Atomic coordinates and structure factors for the reported crystal structures have been deposited in the Protein Data Bank with ID codes 4FQX (pH 5.5) and 4GBX (pH 6.5).
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